ATP8B1 Deficiency Causes Phosphodiesterase 4‐Mediated Glucagon Resistance and Impaired Gluconeogenesis in Mouse and Human Liver
Liver International · 2025
DOI: 10.1111/liv.70306 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, 2025. Verfasst von Jung-Chin Chang und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands. Hauptthemen laut MEDLINE: Gluconeogenesis, Liver, Glucagon, Cyclic Nucleotide Phosphodiesterases, Type 4. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Aims Deficiency of the phospholipid transporter ATP8B1 causes infantile‐onset progressive familial intrahepatic cholestasis type I (PFIC1). Pre‐transplant PFIC1 patients often present with mild dyslipidaemia. This raises the possibility that PFIC1 patients, besides cholestasis, may also experience defects in glucose and lipid metabolism. In this study, we aimed to investigate the role of ATP8B1 in hepatic glucose and lipid metabolism using the Atp8b1 G308V/G308V mutant mouse, a pre‐clinical model of PFIC1.
Methods
Atp8b1 G308V/G308V and wild‐type mice on normal chow were examined. Hepatic glucose metabolism was evaluated by oral glucose tolerance testing, quantification of fasting plasma glucose, insulin and lipids. Mechanistic studies were conducted in primary mouse hepatocytes (PMHs) and HepG2 cells overexpressing glucagon receptor (HepG2‐GCGR). The findings in the mouse model were validated in pre‐transplant livers from PFIC1 patients.
Results
Atp8b1 G308V/G308V mice showed decreased levels of fasting blood glucose, triglycerides and insulin, indicating normal insulin sensitivity and impaired hepatic glucagon response. PMHs from Atp8b1 G308V/G308V mice exhibited reduced glucagon‐dependent cAMP levels and signalling and had increased expression of Pde4 isoforms. Rolipram‐mediated PDE4 inhibition restored glucagon signalling. ATP8B1 knockdown HepG2‐GCGR cells also showed increased PDE4D expression and impaired glucagon signalling. Liver tissue from PFIC1 patients exhibited elevated PDE4D and reduced p‐CREB levels and very low glycogen content.
Conclusions
ATP8B1 deficiency causes upregulation of PDE4D in the liver of Atp8b1 G308V/G308V mice and PFIC1 patients. PDE4D‐mediated glucagon resistance impairs gluconeogenesis and stimulates compensatory glycogenolysis in Atp8b1 G308V/G308V mice and PFIC1 patients. Our study reveals novel metabolic insights of ATP8B1 deficiency in PFIC1 patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands.
- Tytgat Institute for Liver and Intestinal Research, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
- Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
- Graduate Institute of Anatomy and Cell Biology, National Taiwan University College of Medicine, Taipei, Taiwan.
- Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
- Department of Pediatrics I, Medical University of Innsbruck, Innsbruck, Austria.
ORCID-Profile: Wietse In Het Panhuis, Jolie F van der Heiden, Georg F Vogel, Norman Junge, Weng Chuan Peng, Ronald P J Oude Elferink, Huey-Ling Chen, Stan F J van de Graaf, Coen C Paulusma
Zitieren
APA
Chang, J. C., Panhuis, W. I. H., Hsu, S. H., Duijst, S., Ho-Mok, K. S., van der Heiden, J. F., Ying, Z., Erdmann, J. I., Vogel, G. F., Junge, N., Hartleben, B., Koelink, P. J., van Dijk, S. G., Peng, W. C., Verhoeven, A. J., Oude Elferink, R. P. J., Chen, H. L., van de Graaf, S. F. J., & Paulusma, C. C. (2025). ATP8B1 Deficiency Causes Phosphodiesterase 4‐Mediated Glucagon Resistance and Impaired Gluconeogenesis in Mouse and Human Liver. Liver International. https://doi.org/10.1111/liv.70306
Vancouver
Chang JC, Panhuis WIH, Hsu SH, Duijst S, Ho-Mok KS, van der Heiden JF, et al. ATP8B1 Deficiency Causes Phosphodiesterase 4‐Mediated Glucagon Resistance and Impaired Gluconeogenesis in Mouse and Human Liver. Liver International. 2025. doi:10.1111/liv.70306
BibTeX
@article{Chang2025,
author = {Chang, Jung-Chin and Panhuis, Wietse In Het and Hsu, Shu-Hao and Duijst, Suzanne and Ho-Mok, Kam S and van der Heiden, Jolie F and Ying, Zhixiong and Erdmann, Joris I and Vogel, Georg F and Junge, Norman and Hartleben, Björn and Koelink, Pim J and van Dijk, Sebastian G and Peng, Weng Chuan and Verhoeven, Arthur J and Oude Elferink, Ronald P J and Chen, Huey-Ling and van de Graaf, Stan F J and Paulusma, Coen C},
title = {ATP8B1 Deficiency Causes Phosphodiesterase 4‐Mediated Glucagon Resistance and Impaired Gluconeogenesis in Mouse and Human Liver},
journal = {Liver International},
year = {2025},
doi = {10.1111/liv.70306}
}
EUVIMED